1-ethylphenoxathiin 10,10-dioxide has been researched along with n-butylboronic acid in 1 studies
Studies (1-ethylphenoxathiin 10,10-dioxide) | Trials (1-ethylphenoxathiin 10,10-dioxide) | Recent Studies (post-2010) (1-ethylphenoxathiin 10,10-dioxide) | Studies (n-butylboronic acid) | Trials (n-butylboronic acid) | Recent Studies (post-2010) (n-butylboronic acid) |
---|---|---|---|---|---|
6 | 2 | 0 | 23 | 0 | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, SY; Johnson, RL; Johnson, T; St John-Williams, L; Taylor, LC | 1 |
1 other study(ies) available for 1-ethylphenoxathiin 10,10-dioxide and n-butylboronic acid
Article | Year |
---|---|
The use of low-energy collisionally activated dissociation negative-ion tandem mass spectrometry for the characterization of dog and human urinary metabolites of the drug BW 1370U87.
Topics: Animals; Biotransformation; Boron Compounds; Chromatography, High Pressure Liquid; Dogs; Gas Chromatography-Mass Spectrometry; Glucuronates; Heterocyclic Compounds; Humans; Hydroxylation; Male; Mass Spectrometry; Monoamine Oxidase Inhibitors | 1994 |